// App-Quantinova.ai

2522 : Frequency and Early Prediction of Hydroxychloroquine Induced Retinopathy in SLE

Researchers

Presenter

  • Daniel Goldman

Principal Investigators

  • Michelle Petri

Medical Centers

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Johns Hopkins University School of Medicine, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetic retinopathy

Biomarkers

  • Interleukin 1 alpha

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved